Email this article Capability of doppler ultrasonography in prevention of hemorrhagic complications of prostate biopsy
- Authors: Popov S.V.1,2,3, Orlov I.N.1,3, Demidov D.A.1, Suleimanov M.M.1, Gulko A.M.1
-
Affiliations:
- Clinical Hospital of St. Luke
- S.M. Kirov Military Medical Academy
- North-Western State Medical University named after I.I. Mechnikov
- Issue: Vol 9, No 3 (2019)
- Pages: 29-32
- Section: Original articles
- URL: https://journals.rcsi.science/uroved/article/view/17704
- DOI: https://doi.org/10.17816/uroved9329-32
- ID: 17704
Cite item
Abstract
The article presents the results of a comparative study of the frequency and severity of bleeding after prostate biopsy performed under the control of Doppler mode of vascular scanning and without its use. Compared with the usual mode of ultrasound scanning of the prostate, the use of Doppler imaging mode of intraprostatic vessels reduces the number of hemorrhagic complications of prostate biopsy, which confirms the feasibility of using the Doppler mode when taking biopsy material.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Sergey V. Popov
Clinical Hospital of St. Luke; S.M. Kirov Military Medical Academy; North-Western State Medical University named after I.I. Mechnikov
Author for correspondence.
Email: doc.popov@gmail.com
Doctor of Medical Science, Chief Physician; Professor of the Urology Department; Professor of the Urology Department
Russian Federation, Saint PetersburgIgor N. Orlov
Clinical Hospital of St. Luke; North-Western State Medical University named after I.I. Mechnikov
Email: doc.orlov@gmail.com
Candidate of Medical Science, Head of the Urological Unit; Assistant of the Urology Department
Russian Federation, Saint PetersburgDmitry A. Demidov
Clinical Hospital of St. Luke
Email: ddemidov67@mail.ru
urologist
Russian Federation, Saint PetersburgMurad M. Suleimanov
Clinical Hospital of St. Luke
Email: doc-suleimanov@gmail.com
Candidate of Medical Science, urologist
Russian Federation, Saint PetersburgAlexander M. Gulko
Clinical Hospital of St. Luke
Email: agoolko@mail.ru
urologist
Russian Federation, Saint PetersburgReferences
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492.
- Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63-89. https://doi.org/10.14740/wjon1191.
- Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014;384(9959):2027-2035. https://doi.org/10.1016/S0140-6736(14)60525-0.
- Мерабишвили В.М. Злокачественные новообразования в мире, России, Санкт-Петербурге. – СПб.: КОСТА, 2007. – 422 с. [Merabishvili VM. Cancer incidence in the world, Russia, St. Petersburg. Saint Petersburg: KOSTA; 2007. 422 р. (In Russ.)]
- Понкратов С.В., Хейфец В.Х., Каган О.Ф. Диагностическая ценность простатспецифического антигена с учетом возраста пациентов // Урологические ведомости. – 2016. – Т. 6. – № 3. – С. 30–39. [Ponkratov SV, Kheyfets VKh, Kagan OF. Diagnostic value of prostate-specific antigen according to age patients. Urologicheskie vedomosti. 2016;6(3):30-39. (In Russ.)]. https://doi.org/10.17816/uroved6330-39.
- Аполихин О.И., Сивков А.В., Ефремов Г.Д., и др. PCA3 и TMPRSS2-ERG в диагностике рака предстательной железы: первый опыт применения комбинации маркеров в России // Экспериментальная и клиническая урология. – 2015. – № 2. – С. 30–36. [Apolikhin OI, Sivkov AV, Efremov GD, et al. The first Russian experience of using PCA3 and TMPRSS2-ERG for prostate cancer diagnosis. Experimental and Clinical Urology. 2015;(2):30-36. (In Russ.)]
- Коссов Ф.А., Олимов Б.П., Ахвердиева Г.И., и др. Современные возможности лучевой диагностики рака предстательной железы // Вестник рентгенологии и радиологии. – 2017. – Т. 98. – № 6. – С. 327–336. [Kossov FA, Olimov BP, Akhverdieva GI, et al. Current possibilities of radiation diagnosis of prostate cancer. Vestnik rentgenologii i radiologii. 2017;98(6):327-336. (In Russ.)]. https://doi.org/10.20862/0042-4676-2017-98-6-63-70.
- Курнаков А.М., Боровец С.Ю., Аль-Шукри С.Х. Использование доплерографии для дифференциальной диагностики заболеваний предстательной железы // Урологические ведомости. – 2017. – Т. 7. – № 1. – С. 10–14. [Kurnakov AM, Borovets SYu, Al’-Shukri SKh. The use of doppler ultrasound for differential diagnosis of prostate diseases. Urologicheskie vedomosti. 2017;7(1):10-14. (In Russ.)]. https://doi.org/10.17816/uroved7110-14.
- Аль-Шукри С.Х., Курнаков А.М., Боровец С.Ю. Прогнозирование рака предстательной железы с использованием доплерометрического исследования // Урологические ведомости. – 2016. – Т. 6. – № 1. – С. 16–20. [Al’-Shukri SKh, Kurnakov AM, Borovets SYu. Prognosis of prostate cancer using color doppler ultrasonography. Urologicheskie vedomosti. 2016;6(1):16-20. (In Russ.)]. https://doi.org/10.17816/uroved616-20.
Supplementary files
